Patients who responded positively to shunt treatment experienced more beneficial changes in their heart's structure and function compared with nonresponders. After 2 years of follow-up, a post hoc ...

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation The trial met the primary safety ...

The mitral valve allows blood to flow from the left atrium of the heart into the left ventricle. Mitral regurgitation occurs when the mitral valve leaks blood back into the left atrium. A person’s ...

Mitral valve prolapse treatment aims to relieve symptoms, prevent complications, and improve the quality of life of people who have blood that leaks back into their heart’s left atrium. Mitral valve ...

Medtronic has launched a heart implant designed to help lower the lifetime risk of stroke in people with atrial fibrillation and to serve as a valuable addition to patients who are already undergoing ...

BOSTON, MA—Patients with heart failure and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and elevated left atrial pressures appear to derive lasting benefits from a shunt that diverts ...

Erlanger Cardiology completed the first in Chattanooga concomitant left atrial appendage closure (LAAC) and cardiac ablation for atrial fibrillation (AFib) on Nov. 23. Officials said, "This is an ...

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

Heart valves allow blood to flow one way and prevent it from flowing in the wrong direction. The tricuspid valve controls blood flow between the right atrium and right ventricle. The bicuspid or ...